Vasoconstrictor use in liver transplantation: is there evidence for rational use?
Skagen
C L
CL
Department of Medicine, University of Wisconsin, Madison, WI, USA.
Said
A
A
D058625:End Stage Liver Disease / Q000150:complications / Q000601:surgery; D006530:Hepatorenal Syndrome / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000188:drug therapy; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy; D016031:Liver Transplantation; D012307:Risk Factors; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents